Clinical Trials

Showing trials with last updates posted in 2025.

NCT02207465 | ACTIVE_NOT_RECRUITING | PHASE1
42 participants

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2014-07-31
Completion:
2026-12-31
Conditions
  • Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
  • Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
Interventions
  • RADIATION
  • DRUG
No Results Yet
NCT02157883 | COMPLETED | PHASE1
39 participants

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2014-11-06
Completion:
2015-04-03
Conditions
  • Advanced Non Small Cell Lung Cancer
  • Advanced (Inoperable) Non Small Cell Lung Cancer
Interventions
  • PROCEDURE
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page